A blistering disease: bullous erysipelas

Edwards, Janet; Green, Peter; Haase, David
August 2006
CMAJ: Canadian Medical Association Journal;8/1/2006, Vol. 175 Issue 3, p245
Academic Journal
Case Study
Presents a case study of an aged man with non-insulin-dependent diabetes mellitus, who developed bullous erysipelas. Medical history of the patient; Clinical information on bullous erysipelas; Therapeutic management of the condition.


Related Articles

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

  • Combination Therapy for Type 2 Diabetes. Bell, David S. H. // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1812 

    Editorial. Comments on the combination therapy for type 2 diabetes. Effectiveness of sulfonylurea as treatment for type 2 diabetes; Examination of the insulin therapy; Information on the combined insulin and oral therapy.

  • Pathogenesis of Type 2 Diabetes: Implications for Metformin. DeFronzo, R.A. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p29 

    Discusses the implications of the pathogenesis of type 2 diabetes for metformin. Insulin resistance in type 2 diabetes mellitus individuals; Defects in insulin action; Information on the initial therapeutic approach in type 2 diabetes mellitus patients.

  • The Antihyperglycaemic Effect of Metformin: Therapeutic and Cellular Mechanisms. Wiernsperger, N.F.; Bailey, C.J. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p31 

    Metformin is regarded as an antihyperglycaemic agent because it lowers blood glucose concentrations in type 2 (non-insulin-dependent) diabetes without causing overt hypoglycaemia. Its clinical efficacy requires the presence of insulin and involves several therapeutic effects. Of these effects,...

  • Bariatric surgery for obese diabetic subjects.  // Internal Medicine Alert;6/30/2009 Clinical Briefs, p14 

    The article offers findings from a controlled trial in Australia which suggest that surgical therapy can be used as a cost-effective intervention for obesity in type 2 diabetes.

  • VTT searches for novel biomarkers and targets for preventing or treating Type 2 diabetes.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on two projects which aims at identifying new therapeutics and strategies for preventing Type 2 diabetes.

  • Acarbose noninferior to metformin in type 2 diabetes.  // Endocrine Today;Nov2013, Vol. 11 Issue 11, p9 

    The article discusses a research study published in an issue of the journal "The Lancet" which found that patients with type 2 diabetes treated with acarbose experienced similar improvements in HbAlc as those treated with metformin.

  • On "Exercise assessment and prescription in patients with type 2 diabetes...". Gentzel, Joseph B.; Hansen, Dominique; Peeters, Stefaan; Schotte, Michel // Physical Therapy;Aug2013, Vol. 93 Issue 8, p1141 

    A letter to the editor is presented in response to the article "Exercise Assessment and Prescription in Patients With Type 2 Diabetes in the Private and Home Care Setting: Clinical Recommendations From AXXON (Belgian Physical Therapy Association)" by D. Hansen et al. in the May 2013 issue, along...

  • Bariatric Surgery Reduces the Need for Glycemic Control Medications and Related Health Care Costs. Pignone, Michael // Clinical Diabetes;Winter2011, Vol. 29 Issue 1, p34 

    The article discusses a study by M. A. Makary and colleagues which was conducted to determine the effect of bariatric surgery on the use of diabetes medications. The results show that bariatric surgery reduces the requirement for glycemic control medications and related health care costs....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics